Giving Voice to Patient Values Throughout Cancer: A Novel Nurse-Led Intervention.


Journal

Journal of pain and symptom management
ISSN: 1873-6513
Titre abrégé: J Pain Symptom Manage
Pays: United States
ID NLM: 8605836

Informations de publication

Date de publication:
07 2019
Historique:
received: 27 02 2019
revised: 18 04 2019
accepted: 19 04 2019
pubmed: 30 4 2019
medline: 17 3 2020
entrez: 30 4 2019
Statut: ppublish

Résumé

Optimal advance care planning allows patients to articulate their values as a touchstone for medical decision making. Ideally, this occurs when patients are clinically stable, and with opportunities for iteration as the clinical situation unfolds. Testing feasibility and acceptability in busy outpatient oncology clinics of a novel program of systematic, oncology nurse-led values discussions with all new cancer patients. Within an institutional initiative integrating primary and specialist palliative care from diagnosis for all cancer patients, oncology nurses were trained to use specific questions and an empathic communication framework to discuss health-related values during outpatient clinic visits. Nurses summarized discussions on a template for patient verification, oncologist review, and electronic medical record documentation. Summaries were reviewed with the patient at least quarterly. Feasibility and acceptability were evaluated in three clinics for patients with hematologic or gastrointestinal malignancies. Oncology nurses conducted 177 total discussions with 67 newly diagnosed cancer patients (17 with hematologic and 50 with gastrointestinal malignancies) over two years. No patient declined participation. Discussions averaged eight minutes, and all patients verified values summaries. Clinic patient volume was maintained. Of 31 patients surveyed, 30 (97%) reported feeling comfortable with the process, considered it helpful, and would recommend it to others. Clinicians strongly endorsed the values discussion process. Nurse-led discussions of patient values soon after diagnosis are feasible and acceptable in busy oncology clinics. Further research will evaluate the impact of this novel approach on additional patient-oriented outcomes after broader dissemination of this initiative throughout our institution.

Identifiants

pubmed: 31034869
pii: S0885-3924(19)30233-7
doi: 10.1016/j.jpainsymman.2019.04.028
pmc: PMC6849206
mid: NIHMS1057677
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-79.e2

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2019 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Références

J Gen Intern Med. 2001 Jan;16(1):41-9
pubmed: 11251749
J Pain Symptom Manage. 2015 Jun;49(6):974-80.e2
pubmed: 25527441
MedGenMed. 2001 Mar 05;3(2):2
pubmed: 11549951
JAMA Oncol. 2015 Aug;1(5):601-8
pubmed: 26181909
Psychooncology. 2014 Mar;23(3):283-90
pubmed: 24123321
Psychooncology. 2015 Dec;24(12):1767-73
pubmed: 25708116
Health Aff (Millwood). 2018 Jul;37(7):1136-1143
pubmed: 29985699
BMJ Support Palliat Care. 2017 Sep;7(3):292-299
pubmed: 28827369
JAMA Intern Med. 2017 Sep 1;177(9):1361-1366
pubmed: 28672373
Am J Hosp Palliat Care. 2018 Mar;35(3):532-541
pubmed: 28627287
CMAJ. 2014 Dec 9;186(18):E679-87
pubmed: 25367427
J Pain Symptom Manage. 2018 Aug;56(2):169-177.e1
pubmed: 29729347
JAMA Intern Med. 2014 Dec;174(12):1994-2003
pubmed: 25330167
J Palliat Med. 2018 Jul;21(7):893-894
pubmed: 29975611
J Palliat Med. 2013 Jun;16(6):661-8
pubmed: 23662953
BMJ Open. 2015 Oct 06;5(10):e009032
pubmed: 26443662
Ann Intern Med. 2010 Aug 17;153(4):256-61
pubmed: 20713793
J Clin Oncol. 2004 Apr 1;22(7):1336-40
pubmed: 15051784
JAMA Intern Med. 2014 Jul;174(7):1093-4
pubmed: 24861458
J Oncol Pract. 2014 Nov;10(6):e396-403
pubmed: 25294393
Contemp Clin Trials. 2017 Mar;54:98-104
pubmed: 28104470
J Oncol Pract. 2015 Mar;11(2):e230-8
pubmed: 25784580
Am J Hosp Palliat Care. 2017 Dec;34(10):918-924
pubmed: 28196448
Hastings Cent Rep. 2009 Mar-Apr;39(2):31-7
pubmed: 19388384
J Clin Oncol. 2017 Jan;35(1):96-112
pubmed: 28034065
J Pain Symptom Manage. 2017 May;53(5):821-832.e1
pubmed: 28062339
J Pain Symptom Manage. 2018 Feb;55(2):245-255.e8
pubmed: 28865870
Int J Nurs Stud. 2017 Feb;67:31-40
pubmed: 27912108
J Palliat Med. 2003 Aug;6(4):593-603
pubmed: 14516501
Blood Rev. 2012 Nov;26(6):233-9
pubmed: 22874874
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
JAMA Intern Med. 2018 Jul 1;178(7):930-940
pubmed: 29802770
Crit Care Med. 2010 Mar;38(3):743-50
pubmed: 20029347
BMJ. 2005 Jan 22;330(7484):182
pubmed: 15564228
J Oncol Pract. 2018 Dec;14(12):e775-e785
pubmed: 30537456
Psychooncology. 2017 Jun;26(6):866-869
pubmed: 27270829
Semin Oncol Nurs. 2018 Aug;34(3):316-326
pubmed: 30100366
J Palliat Med. 2015 Mar;18(3):232-40
pubmed: 25517219
J Palliat Med. 2018 Apr;21(4):522-528
pubmed: 29360417
J Natl Compr Canc Netw. 2016 Jan;14(1):82-113
pubmed: 26733557

Auteurs

Andrew S Epstein (AS)

Memorial Sloan Kettering Cancer Center, New York, New York, USA; Weill Cornell Medical College, New York, New York, USA. Electronic address: epsteina@mskcc.org.

Anjali V Desai (AV)

Memorial Sloan Kettering Cancer Center, New York, New York, USA; Weill Cornell Medical College, New York, New York, USA.

Camila Bernal (C)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Danielle Romano (D)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Peter J Wan (PJ)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Molly Okpako (M)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Kelly Anderson (K)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Kimberly Chow (K)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Dana Kramer (D)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Claudia Calderon (C)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Virginia V Klimek (VV)

Memorial Sloan Kettering Cancer Center, New York, New York, USA; Weill Cornell Medical College, New York, New York, USA.

Robin Rawlins-Duell (R)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Diane L Reidy (DL)

Memorial Sloan Kettering Cancer Center, New York, New York, USA; Weill Cornell Medical College, New York, New York, USA.

Jessica I Goldberg (JI)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Elizabeth Cruz (E)

Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Judith E Nelson (JE)

Memorial Sloan Kettering Cancer Center, New York, New York, USA; Weill Cornell Medical College, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH